Proxy filing
Logotype for ResMed Inc

ResMed (RMD) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for ResMed Inc

Proxy filing summary

6 Nov, 2026

Executive summary

  • Annual meeting scheduled for Nov. 18, 2026, at 3:00 p.m. US Pacific Time and Nov. 19 at 10:00 a.m. Australian Eastern Time, via live webcast.

  • Agenda covers election of 10 directors, auditor ratification for FY ending June 30, 2027, and an advisory vote on named executive officer compensation.

Voting matters and shareholder proposals

  • Board recommends voting For all three matters: director elections, PwC LLP auditor ratification, and advisory approval of named executive officer compensation.

Board of directors and corporate governance

  • Ten nominees—Carol Burt, Jan De Witte, Christopher DelOrefice, Karen Drexler, Michael Farrell, Peter Farrell, Harjit Gill, John Hernandez, Nicole Mowad-Nassar, and Desney Tan—are nominated to serve until the 2027 annual meeting and until successors are elected and qualified.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from ResMed